CAP-7.1

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug NameCAP-7.1

Drug Alias NameEtoposide toniribateEtoposide prodrug (CAP7.1)EDO-S7.1CAP-7.1ProVP-16I

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionDNA intercalatorsTopoisomerase II inhibitors

TargetsTopoisomerase IIDNA

Therapy Area/IndicationsSolid tumours

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryGermany

CombinationsNo

Global Highest StatusDiscontinued (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesCellact Pharma

China Registration ClassN/A

Active CompaniesN/A

Active IndicationsN/A

Inactive IndicationsSolid tumours

ATC CodeN/A